Gum arabic
(Synonyms: 阿拉伯胶, Arabic gum) 目录号 : GC20149
Cas No.:9000-01-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 9000-01-5 | SDF | |
| 别名 | 阿拉伯胶, Arabic gum | ||
| 分子式 | 分子量 | N/A | |
| 溶解度 | < 1 mg/ml refers to the product slightly soluble or insoluble | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Gum arabic as an environmentally sustainable polymeric anticorrosive material: Recent progresses and future opportunities
Int J Biol Macromol 2021 Aug 1;184:118-134.PMID:34119540DOI:10.1016/j.ijbiomac.2021.06.050.
Gum arabic (GA) is a plant exudate, consisting of glycoproteins (proteins with carbohydrate co-factor or prosthetic group) and polysaccharides mainly consisting of galactose and arabinose. Because of its polymeric nature and tendency to dissolve in water, GA is widely used as anticorrosive materials, especially in the aqueous electrolytes. GA contains various electron rich polar sites through which they easily get adsorbed on metallic surface and behaves as effective anticorrosive materials. Because of its natural and biological origin, GA is regarded as one of the environmental sustainable and edible alternatives to traditional toxic corrosion inhibitors. Present review piece of writing aims to illustrate the assortment of literatures on Gum arabic as a corrosion inhibitor. Limitation of traditional organic corrosion inhibitors and advantages of using GA as an environmental sustainable alternative have also been described along with the mechanism of corrosion inhibition.
Gum arabic capped copper nanoparticles: Synthesis, characterization, and applications
Int J Biol Macromol 2020 Mar 1;146:232-242.PMID:31904465DOI:10.1016/j.ijbiomac.2019.12.260.
In present work, we synthesized copper nanoparticles using l-ascorbic acid as a reducing agent and capped them with Gum arabic. Based upon spectrometric analysis and particle size distribution (19.60-35.06 nm) by intensity, a 1% concentration of Gum arabic was selected as the suitable capping agent for copper nanoparticles. Gum arabic capped copper nanoparticles revealed significantly (p < 0.05) higher zeta potential value than that of unmodified copper nanoparticles. Energy-dispersive X-ray spectroscopy revealed the purity of the copper nanoparticles, whereas scanning electron microscopy confirmed the polygonal prismatic shape of the Gum arabic capped copper nanoparticles. As well, TEM analysis confirmed the monodispersed nature of the Gum arabic capped copper nanoparticles. Gum arabic capped copper nanoparticles showed significantly (p < 0.05) higher zone of inhibition for Salmonella typhimurium (27 mm) than that of other bacterial strains. Approximately 95% photocatalytic degradation of methylene blue and crystal violet was observed within 40 and 20 min. As well, both unmodified and Gum arabic capped copper nanoparticles were found to be non-toxic to Caco-2 cells during cell viability assay.
A Review on the Main Phytoconstituents, Traditional Uses, Inventions, and Patent Literature of Gum arabic Emphasizing Acacia seyal
Molecules 2022 Feb 9;27(4):1171.PMID:35208961DOI:10.3390/molecules27041171.
Acacia seyal is an important source of Gum arabic. The availability, traditional, medicinal, pharmaceutical, nutritional, and cosmetic applications of gum acacia have pronounced its high economic value and attracted global attention. In addition to summarizing the inventions/patents applications related to gum A. seyal, the present review highlights recent updates regarding its phytoconstituents. Traditional, cosmetic, pharmaceutical, and medicinal uses with the possible mechanism of actions have been also reviewed. The patent search revealed the identification of 30 patents/patent applications of A. seyal. The first patent related to A. seyal was published in 1892, which was related to its use in the prophylaxis/treatment of kidney and bladder affections. The use of A. seyal to treat cancer and osteoporosis has also been patented. Some inventions provided compositions and formulations containing A. seyal or its ingredients for pharmaceutical and medical applications. The inventions related to agricultural applications, food industry, cosmetics, quality control of Gum arabic, and isolation of some chemical constituents (L-rhamnose and arabinose) from A. seyal have also been summarized. The identification of only 30 patents/patent applications from 1892 to 15 November 2021 indicates a steadily growing interest and encourages developing more inventions related to A. seyal. The authors recommend exploring these opportunities for the benefit of society.
Acacia gum (Gum arabic): a nutritional fibre; metabolism and calorific value
Food Addit Contam 1998 Apr;15(3):251-64.PMID:9666883DOI:10.1080/02652039809374639.
Gum arabic (Acacia gum, INS 414: E414) is extensively used as a food additive, but there is no regulatory or scientific consensus about its calorific value. It is a complex polysaccharide, primarily indigestible to both humans and animals, not degraded in the intestine, but fermented in the colon under the influence of microorganisms. Despite a range of animal studies, there are no usable data for humans which can quantify the utilizable energy of Gum arabic. Estimates in the literature from animal experiments vary from 0 to 4 kcal/g. After certain allowances are made for the energy losses from volatile and gaseous fermentation products, an upper level of 2 kcal/g for rats has been set. The situation in man is demonstrably different, with greatly reduced amounts of such products, and the need to adapt for varying periods before Gum arabic is attacked by colonic bacteria. In the absence of an agreed scientific assignment, the FDA in the USA insist upon 4 kcal/g in nutritional labelling, whereas in Europe, no value has been assigned to soluble dietary fibre, such as Gum arabic. This review argues that based on present scientific knowledge only an arbitrary value can be used for regulatory purposes.
The Efficacy of Gum arabic in Managing Diseases: A Systematic Review of Evidence-Based Clinical Trials
Biomolecules 2023 Jan 9;13(1):138.PMID:36671523DOI:10.3390/biom13010138.
Gum arabic (GA) is a natural product commonly used as a household remedy for treating various diseases in the Sub-Saharan Africa region. Despite its claimed benefits, there has been a lack of research on the findings of current clinical trials (CTs) that investigated its efficacy in the treatment of various medical diseases. The aim of this systematic review was to study CTs which focused on GA and its possible use in the management of various medical diseases. A search of the extant literature was performed in the PubMed, Scopus, and Cochrane databases to retrieve CTs focusing on evidence-based clinical indications. The databases were searched using the keywords ("Gum arabic" OR "Acacia senegal" OR "Acacia seyal" OR "Gum Acacia" OR "Acacia Arabica") AND ("Clinical Trial" OR "Randomized Controlled Trial" OR "Randomized Clinical Trial"). While performing the systematic review, data were obtained on the following parameters: title, authors, date of publication, study design, study aim, sample size, type of intervention used, targeted medical diseases, and main findings. Twenty-nine papers were included in this systematic review. The results showed that ingestion of GA altered lipid profiles, renal profiles, plaque, gingival scores, biochemical parameters, blood pressure, inflammatory markers, and adiposity. GA exhibited anti-inflammatory, prebiotic, and antibacterial properties. GA has been successfully used to treat sickle cell anemia, rheumatoid arthritis, metabolic disorders, periodontitis, gastrointestinal conditions, and kidney diseases. Herein, we discuss GA with respect to the underlying mechanisms involved in each medical disease, thereby justifying GA's future role as a therapeutic agent.